Viewing Study NCT06517758


Ignite Creation Date: 2025-12-25 @ 12:17 AM
Ignite Modification Date: 2026-01-02 @ 1:00 PM
Study NCT ID: NCT06517758
Status: RECRUITING
Last Update Posted: 2025-12-17
First Post: 2024-02-12
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Phase III Study to Investigate Efficacy, Safety and Tolerability of Iptacopan Compared With Placebo in Participants Aged 18 to 75 Years With gMG.
Sponsor: Novartis Pharmaceuticals
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module